Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigenic variation in vector-borne pathogens.

A G Barbour1, B I Restrepo

  • 1University of California Irvine, Irvine, California 92697-4025, USA. abarbour@uci.edu

Emerging Infectious Diseases
|September 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and evaluation of the phenotypic 2G test to detect drug-resistant TB.

IJTLD open·2025
Same author

Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.

Epidemiology and infection·2019
Same author

Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico.

Epidemiology and infection·2017
Same author

Borrelia miyamotoi infection in nature and in humans.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Type 2 diabetes and tuberculosis in a dynamic bi-national border population.

Epidemiology and infection·2006

Vector-borne pathogens use antigenic variation to evade host immunity and ensure transmission. These adaptable mechanisms, seen in bacteria and parasites, challenge vaccine development against infectious diseases.

Area of Science:

  • Microbiology and Immunology
  • Parasitology
  • Infectious Diseases

Background:

  • Many human and animal pathogens rely on arthropod vectors for transmission between hosts.
  • Pathogen survival and transmission are enhanced by antigenic variation, a mechanism to evade host immune responses.
  • Vector-borne diseases pose significant threats to public health and animal agriculture.

Purpose of the Study:

  • To explore the convergent evolution of antigenic variation mechanisms in diverse vector-borne pathogens.
  • To highlight the genetic strategies employed by bacteria and parasites for immune evasion.
  • To underscore the implications of antigenic variation for vaccine development.

Main Methods:

  • Comparative analysis of genetic mechanisms across different pathogen groups (bacteria and parasites).

Related Experiment Videos

  • Review of existing literature on antigenic variation in key vector-borne pathogens.
  • Identification of common evolutionary pathways in immune evasion strategies.

    • Main Results:

    • Vector-borne bacterial and protozoal pathogens have convergently evolved similar genetic mechanisms for antigenic variation.
    • Examples include Borrelia spp., Anaplasma marginale, African trypanosomes, Plasmodium falciparum, and Babesia bovis.
    • These mechanisms allow pathogens to persist in the bloodstream and increase transmission probability.

    Conclusions:

    • Antigenic variation is a critical factor for the success of many vector-borne pathogens.
    • The shared genetic strategies emphasize the evolutionary pressure for immune evasion.
    • Developing effective vaccines against these pathogens is complicated by their capacity for antigenic variation.